'Companies have strong incentives to resist studies that could suggest they are responsible for harms involving their products. That’s why future studies will depend on innovations in adversarial data access, ethics and privacy. Researchers should prioritize methods that don’t rely on companies, while supporting laws to require algorithm makers to collaborate with researchers.'